Find your path to Andy
93 people in our graph share verified history with Andy β schools, employers, funds. One of them is your warm intro.
Lars PedersenunlockedAndy: together at Yale School of Medicine
Andy: together at University of Geneva
Γ10Andy: together at Yale School of Medicine
Chief Scientific Officer at Enshorx
Intro paths
β
In turn, Andy can intro founders to Enshorx's investors below.
Enshorx's investors Β· 2
Co-founders at Enshorx
NB
Neena Bitritto-GargFounder
Experience
- Ensho TherapeuticsChief Scientific Officercurrent2024 β present
- Choucas Consulting LLCPrincipalcurrent2023 β present
- Applied Molecular TransportSVP, Research and Translational Science2022 β 2023
- Applied Molecular TransportVP, Preclinical Development and Translational Science2019 β 2022
- BridgeBioVice President Biology in Residence2018 β 2019
- Gilead SciencesDirector, Biology2012 β 2018Seattle, WA
- Gilead SciencesDirector, Structural Chemistry2010 β 2012Branford, CT
- CGI Pharmaceuticals, Inc.Senior Director/Project Leader, Inflammation and Autoimmune Disease2008 β 2010Branford, CT
- CGI Pharmaceuticals, Inc.Senior Director, Biology and Informatics2005 β 2008Branford, CT
- CGI Pharmaceuticals, Inc.Director/Principal Scientist/Senior Scientist, Research Informatics1999 β 2005Branford, CT
- University of GenevaPostdoctoral Fellow1995 β 1999Switzerland
- Harvard Medical SchoolResearch Associate1985 β 1988Boston, MA
Skills & more
Biomarker DevelopmentTranslational Research1Translational MedicineClinical TrialsResource ManagementResource AllocationEmerging TrendsResearch PlanningMedical ResearchStrategic ThinkingTeamworkExecutive Team
+8 more
CancerAnalytical SkillsAnti-inflammatoryDrug DiscoveryOncologyCell BiologyBiotechnologyDrug DevelopmentFrom Andy's professional profile.
Frequently asked questions
- Who is Andy Whitney?
- Chief Scientific Officer at Enshorx
- Where does Andy Whitney work?
- Andy Whitney is Chief Scientific Officer at Enshorx.
- Where did Andy Whitney go to school?
- Andy Whitney studied at Yale School of Medicine (PhD, Cell Biology); Harvard University (A.B.).
Same school
Also attended Yale School of Medicine73
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpElias QuijanoPrincipal at Northpond VenturesJeffrey LowPartner at Averin CapitalBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalAlley (Welsh) OlshanskyAdvisor at Casdin Capital
+ 67 more
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Shared employers
Also worked at Ensho Therapeutics1
Also worked at BridgeBio10
Colin WangPartner at Wuxi Healthcare Ventures Management Us LlcWonpyo YunPrincipal at Aisling CapitalAlex AmenAdvisor at PsyMed VenturesLeyi WangPartner at 6 Dimensions CapitalChris GreenoAssociate at Asahi Kasei Corporate Venture CapitalMichael HendersonFounder at Apogee Therapeutics
+ 4 more
Also worked at Gilead Sciences53
Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLaura QuockCBO-in-Residence at Versant VenturesLan WuAnalyst at FusionAriel RahamimAn investor in pre-seed and idea stage startups
+ 47 more
Also worked at University of Geneva21
Marco PrunottoInvestor at MedicxiHadrien BouchezPartner at Kurma PartnersVincent OssipowPartner at Omega FundsPeter DudekPresident at MRL Ventures FundMarc CikesManaging Director at Debiopharm Innovation FundKris KaczmarekInvestment Director at QDNL Participations
+ 15 more
































